Benefits
Joint Health and Osteoarthritis Support
Boswellin demonstrated to support joint health and reduce OA symptoms; multiple clinical trials show improvements in WOMAC scores, joint mobility, and inflammatory markers.
Anti-Inflammatory via 5-LOX Inhibition
Boswellic acids inhibit 5-lipoxygenase (5-LOX) enzyme — produces inflammatory leukotrienes; mechanism distinct from NSAID COX inhibition.
Inflammatory Bowel Adjunct
Boswellia traditional and modern applications include IBD adjunct; some evidence for ulcerative colitis and Crohn's symptom support.
Multiple Standardized Variants
Sabinsa offers multiple Boswellin variants for different applications: standard Boswellin, Boswellin Super (high AKBA), Boswellin PS (Phytosome with curcumin), Boswellin CG.
Long Traditional Use
Boswellia (Indian frankincense) used for over 2,000 years in Ayurveda for joint and inflammatory conditions.
Patented Sabinsa Standardization
Sabinsa's patented standardization processes ensure consistent boswellic acid content and clinical reproducibility.
Mechanism of action
5-Lipoxygenase (5-LOX) Inhibition
Boswellic acids inhibit 5-LOX — enzyme producing leukotrienes (inflammatory mediators); distinguishes from NSAID COX-only inhibition; relevant for inflammatory conditions where leukotrienes are central.
AKBA (Acetyl-11-Keto-Beta-Boswellic Acid) — Most Active
AKBA is the most potent boswellic acid for 5-LOX inhibition; Boswellin Super has higher AKBA content (typically 20-30%) vs standard Boswellin.
Cathepsin G Inhibition
Boswellic acids inhibit cathepsin G protease — additional anti-inflammatory mechanism.
TNF-α and NF-κB Pathway Modulation
Reduces TNF-α and modulates NF-κB inflammatory signaling.
Cartilage Matrix Protection
Inhibits matrix metalloproteinases (MMPs) — relevant to joint protection.
Clinical trials
Multiple boswellia/AKBA RCTs in OA patients.
OA patients across studies.
Significant improvements in WOMAC scores, joint mobility, inflammation markers.
Sabinsa clinical studies of Boswellin variants for joint and inflammatory applications.
Adults with joint or inflammatory concerns.
Joint comfort improvements; inflammatory marker reductions.
About this ingredient
BOSWELLIN® is a STANDARDIZED BOSWELLIA SERRATA GUM RESIN EXTRACT developed by SABINSA CORPORATION — among the most-recognized boswellia branded ingredients globally. BOSWELLIA SERRATA BACKGROUND: tree resin (also called 'Indian frankincense' or 'Salai Guggul'); used in AYURVEDA for over 2,000 years for joint health and inflammatory conditions. BOSWELLIC ACIDS: triterpene compounds; the active compounds; AKBA (acetyl-11-keto-beta-boswellic acid) is most potent for 5-LOX inhibition. SABINSA BOSWELLIN VARIANTS: (1) BOSWELLIN® standard — 65% boswellic acids; (2) BOSWELLIN® SUPER — high AKBA (20-30%); (3) BOSWELLIN® PS — curcumin-boswellia phytosome combination; (4) BOSWELLIN® CG — curry gum variant.
KEY DISTINCTIONS: (1) PATENTED Sabinsa standardization; (2) MULTIPLE VARIANTS for different applications; (3) Long clinical research history; (4) Self-affirmed GRAS; (5) Among Sabinsa's flagship ingredients.
EVIDENCE-BASED USES: (1) Joint health and OA support; (2) Anti-inflammatory via 5-LOX inhibition; (3) IBD adjunct (some evidence); (4) Sports recovery; (5) Inflammatory conditions.
CRITICAL CAUTIONS: (1) PREGNANCY — limited safety data; AVOID; (2) PRE-SURGERY — discontinue 1-2 weeks before; (3) ANTICOAGULANTS — modest effects; (4) DOSE — 100-400 mg/day variants; per Sabinsa specification; (5) DURATION — joint effects build over 4-12 weeks; (6) BOSWELLIN vs CASPEROME (Indena) — different standardization approaches; Boswellin offers AKBA-emphasized variants; Casperome offers Phytosome bioavailability + full-spectrum 11 boswellic acids; both have evidence; (7) FOR JOINT HEALTH — comprehensive approach: exercise, weight management, possibly NSAIDs when warranted, multiple natural options; (8) AKBA-FOCUSED vs FULL-SPECTRUM — Boswellin Super emphasizes potent AKBA; some evidence full-spectrum better matches natural resin activity; both work; (9) BOSWELLIA + CURCUMIN COMBINATION — Boswellin PS combines both; common synergistic combination for joint health; (10) BRAND VERIFICATION — Boswellin® is Sabinsa trademark; specific patented standardization; clinical evidence on this branded form; (11) Among the most evidence-based boswellia ingredients with extensive Sabinsa research.